Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease
- 11 January 2017
- journal article
- research article
- Published by Taylor & Francis in Redox Report
- Vol. 22 (3) , 127-136
Abstract
Objectives: Determine the effects of a 12-month exercise and lifestyle intervention program on changes in plasma biomarkers of oxidative stress in pre-dialysis chronic kidney disease (CKD) patients. Methods: A total of 136 stage 3–4 CKD patients were randomized to receive standard nephrological care with (N = 72) or without (N = 64) a lifestyle and exercise intervention for 12 months. Plasma total F2-isoprostanes (IsoP), glutathione peroxidase (GPX) activity, total antioxidant capacity (TAC), anthropometric and biochemical data were collected at baseline and at 12 months. Results: There were no significant differences between groups at baseline. There were no significant differences in changes for standard care and lifestyle intervention, respectively, in IsoP (p = 0.88), GPX (p = 0.87), or TAC (p = 0.56). Patients identified as having high IsoP at baseline (>250 pg/mL) had a greater decrease in IsoP with lifestyle intervention compared to standard care; however, the difference was not statistically significant (p = 0.06). There was no difference in the change in kidney function (eGFR) between standard care and lifestyle intervention (p = 0.33). Discussion: Exercise and lifestyle modification in stage 3–4 CKD did not produce changes in systemic biomarkers of oxidative stress over a 12-month period, but patients with high IsoP may benefit most from the addition of intervention to standard care.Keywords
Funding Information
- National Health and Medical Research Council (511081)
- University of Queensland
This publication has 43 references indexed in Scilit:
- The Impact of Body Weight Management in Chronic Kidney Disease Patients With ObesityJournal of Renal Nutrition, 2013
- Effects of Exercise and Lifestyle Intervention on Cardiovascular Function in CKDClinical Journal of the American Society of Nephrology, 2013
- Antioxidants for chronic kidney diseaseCochrane Database of Systematic Reviews, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CNew England Journal of Medicine, 2012
- Importance of understanding pre-analytical variability in biomarker developmentInternational Journal of Cardiology, 2011
- Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney diseaseNephrology Dialysis Transplantation, 2011
- HDL is the major lipoprotein carrier of plasma F2-isoprostanesJournal of Lipid Research, 2009
- Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin CClinical Journal of the American Society of Nephrology, 2008
- Antioxidative Effects of Exercise Training in Patients With Chronic Heart FailureCirculation, 2005
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004